MediPoint: Hydrocolloids - Global Analysis and Market Forecasts

MediPoint: Hydrocolloids - Global Analysis and Market Forecasts

Summary

Hydrocolloids include: Antimicrobial Hydrocolloid Dressings, Non Antimicrobial Hydrocolloid Dressings.

Growth in the hydrocolloid dressings market is driven by: Use with compression therapy, Flap construction with hydrocolloid dressing template.

The global market for urology endoscopes is led by: 3M Health care, Smith & Nephew Plc (Smith & Nephew), ConvaTec Group Plc (ConvaTec), Coloplast A/S (Coloplast).

Scope

- Competitive assessment: Currently marketed Hydrocolloids and evolving competitive landscape
- In-depth analysis of unmet needs and adoption trends of different Hydrocolloids
- Insightful review of the key industry drivers, opportunities, restraints and challenges.
- Annualized total Hydrocolloids market revenue by segment and market outlooks from 2017-2024.
- Other key topics covered include strategic competitive assessment, identification of unmet needs, and market dynamics.

Reasons to buy

The report will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Hydrocolloids market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Hydrocolloids market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific Hydrocolloids market from 2017-2024.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

1 About the Authors 2
2 3
2.1 List of Tables 6
2.2 List of Figures 6
3 Executive Summary 7
3.1 Overview 7
3.2 Market Dynamics 14
3.3 Key Players in the Market 14
3.4 Market Future Outlook 14
4 Introduction 16
4.1 Catalyst 16
4.2 Related Reports 16
4.3 Upcoming Related Reports 16
5 Market Outlook 17
5.1 Procedure Trends 17
5.2 Revenue Trends 24
5.3 Company Share Analysis 30
6 Market Access 33
6.1 Regulatory Issues 33
6.1.1 North America 33
6.1.2 Europe 37
6.1.3 APAC 57
6.1.4 South America 64
6.1.5 Middle East and Africa 67
6.2 Pricing Trends 74
6.2.1 North America 74
6.2.2 Europe 75
6.2.3 APAC 77
6.2.4 South America 78
6.2.5 Middle East and Africa 78
7 Opportunities, Unmet Needs and Barriers 79
7.1 Opportunities 79
7.1.1 Maggot Therapy 79
7.1.2 Use with compression therapy 79
7.1.3 Flap construction with hydrocolloid dressing template 80
7.2 Unmet Needs 80
7.2.1 Wound maceration and hypergranulation 80
7.2.2 Clearer gels for wound assessment 80
7.2.3 Efficacy of antimicrobials 80
7.3 Barriers 81
7.3.1 Lack of reimbursement 81
7.3.2 Regulatory issues 81
7.3.3 Lack of clinical data 82
8 Market Insights 83
8.1 Overview 83
8.2 North America 83
8.2.1 Canada 83
8.2.2 Mexico 83
8.2.3 US 83
8.3 Europe 84
8.3.1 Denmark, Finland, Norway, and Sweden 84
8.3.2 Belgium, France, and Netherlands 85
8.3.3 Germany and Switzerland 85
8.3.4 UK and Ireland 85
8.3.5 Italy, Portugal, and Spain 86
8.3.6 Austria, Czech Republic, Hungary, and Poland 86
8.3.7 Greece, Russia, and Turkey 86
8.4 APAC 87
8.4.1 Australia and New Zealand 87
8.4.2 China and Taiwan 87
8.4.3 India 87
8.4.4 Japan 88
8.4.5 South Korea 88
8.5 South America 88
8.5.1 Brazil 88
8.5.2 Argentina and Chile 89
8.6 Middle East and Africa 89
8.6.1 Israel 89
8.6.2 South Africa 89
8.6.3 Egypt, Saudi Arabia, and United Arab Emirates 89
9 Competitive Assessment 90
9.1 Overview 90
9.2 Mergers and Acquisitions 90
9.3 3M Health care 90
9.3.1 Overview 90
9.3.2 Portfolio Assessment 91
9.3.3 Competitive Positioning 91
9.4 Smith & Nephew 92
9.4.1 Overview 92
9.4.2 Portfolio Assessment 92
9.4.3 Competitive Positioning 92
9.5 ConvaTec 93
9.5.1 Overview 93
9.5.2 Portfolio Assessment 93
9.5.3 Competitive Positioning 94
9.6 Coloplast 94
9.6.1 Overview 94
9.6.2 Portfolio Assessment 95
9.6.3 Competitive Positioning 95
9.7 Other Players 96
10 Appendix 97
10.1 Bibliography 97
10.2 Abbreviations 97
10.3 Methodology 105
10.3.1 Coverage 105
10.3.2 Secondary Research 105
10.3.3 Forecasting Methodology 106
10.3.4 Primary Research Summary 107
10.4 About MediPoint 108
10.5 About GlobalData 108
10.6 Contact Us 108
10.7 Disclaimer 109

List Of Tables

List of Tables
Table 1: Key Metrics in the Global hydrocolloid Market 7
Table 2: North America Hydrocolloid Dressings Volume Forecast, 2015 -2024 (in thousands) 17
Table 3: Europe Hydrocolloid Dressings Volume Forecast, 2015 - 2024 (in thousands) 18
Table 4: APAC Hydrocolloid Dressings Volume Forecast, 2015 - 2024 (in thousands) 21
Table 5: South America Hydrocolloid Dressings Volume Forecast, 2015 - 2024 (in thousands) 22
Table 6: Middle East and Africa Hydrocolloid Dressings Volume Forecast, 2015 - 2024 (in thousands) 23
Table 7: North America Hydrocolloid Dressings Market Revenue Forecast ($M), 2015 -2024 24
Table 8: Europe Hydrocolloid Dressings Revenue Forecast ($M), 2015 -2024 25
Table 9: APAC Hydrocolloid Dressings Market Revenue Forecast ($M), 2015 -2024 28
Table 10: South America Hydrocolloid Dressings Market Revenue Forecast ($M), 2015-2024 29
Table 11: Middle East and Africa Hydrocolloid Dressings Market Revenue Forecast ($M), 2015-2024 30
Table 12: North America Hydrocolloid Dressings Company Share Analysis, 2017 30
Table 13: Europe Hydrocolloid Dressings Company Share Analysis, 2017 31
Table 14: APAC Hydrocolloid Dressings Company Share Analysis, 2017 32
Table 15: South America Hydrocolloid Dressings Company Share Analysis, 2017 32
Table 16: Middle East and Africa Hydrocolloid Dressings Company Share Analysis, 2017 32
Table 17: North America Hydrocolloid Dressings Average Selling Price Forecast ($), 2015 -2024 74
Table 18: Europe Hydrocolloid Dressings Average Selling Price Forecast ($), 2015 -2024 75
Table 19: APAC Hydrocolloid Dressings Average Selling Price Forecast ($), 2015-2024 77
Table 20: South America Hydrocolloid Dressings Average Selling Price Forecast ($), 2015-2024 78
Table 21: Middle East and Africa Hydrocolloid Dressings Average Selling Price Forecast ($), 2015-2024 78
Table 22: Mergers and Acquisitions, 2017 90
Table 23: 3M Healthcare - Key Marketed Products Assessment 91
Table 24: Summary of Other Players in the 3M Healthcare in the Hydrocolloid Dressings Market, 2017 91
Table 25: Smith & Nephew - Key Marketed Products Assessment 92
Table 26: SWOT Analysis of Smith & Nephew in the Hydrocolloid Dressings Market, 2017 93
Table 27: ConvaTec - Key Marketed Products Assessment 93
Table 28: SWOT Analysis of ConvaTec in the Hydrocolloid dressings Market, 2017 94
Table 29: Coloplast - Key Marketed Products Assessment 95
Table 30: SWOT Analysis of Coloplast in the Hydrocolloid dressings Market, 2017 95
Table 31: Summary of Other Players in the Hydrocolloid Dressings Market, 2017 96

List Of Figures

List of Figures
Figure 1: Hydrocolloids Global Sales, by Region, 2017 and 2024 8
Figure 2: Hydrocolloids Sales for North America, by Country, 2017 and 2024 9
Figure 3: Hydrocolloids Sales for Europe, by Country, 2017 and 2024 10
Figure 4: Hydrocolloids Sales for APAC, by Country, 2017 and 2024 11
Figure 5: Hydrocolloids Sales for South America, by Country, 2017 and 2024 12
Figure 6: Hydrocolloids Sales for the Middle East and Africa, by Country, 2017 and 2024 13

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available